|
LM_ID
|
Common Name
|
Systematic Name
|
Main class
|
Sub class
|
Mass
|
Formula
|
|
LMFA01050574
|
Gallicynoic acid E
|
3,11,14-trihydroxy-octadeca-9-en-12-ynoic acid
|
Fatty Acids and Conjugates [FA01]
|
Hydroxy fatty acids [FA0105]
|
326.21
|
C18H30O5
|
|
LMFA02000031
|
2R-HpOTrE
|
2R-hydroperoxy-9Z,12Z,15Z-octadecatrienoic acid
|
Octadecanoids [FA02]
|
Other Octadecanoids [FA0200]
|
326.21
|
C18H30O5
|
|
LMFA02000058
|
9K,12,13-diHODE
|
9-oxo-12,13-dihydroxy-10E,15Z-octadecadienoic acid
|
Octadecanoids [FA02]
|
Other Octadecanoids [FA0200]
|
326.21
|
C18H30O5
|
|
LMFA02000362
|
|
6,9R,10R-trihydroxy-7E12Z,15Z-octadecatrienoic acid
|
Octadecanoids [FA02]
|
Other Octadecanoids [FA0200]
|
326.21
|
C18H30O5
|
|
LMFA02000361
|
|
6,9R,10S-trihydroxy-7E12Z,15Z-octadecatrienoic acid
|
Octadecanoids [FA02]
|
Other Octadecanoids [FA0200]
|
326.21
|
C18H30O5
|
|
LMFA02030037
|
16-D1c-PhytoP
|
8-((1R,2S,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030035
|
16-D1t-PhytoP
|
8-((1S,2R,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030053
|
16-E1c-PhytoP
|
8-((1R,2S,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030051
|
16-E1t-PhytoP
|
8-((1S,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030038
|
16-epi-16-D1c-PhytoP
|
8-((1R,2S,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030036
|
16-epi-16-D1t-PhytoP
|
8-((1S,2R,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030054
|
16-epi-16-E1c-PhytoP
|
8-((1R,2S,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030052
|
16-epi-16-E1t-PhytoP
|
8-((1S,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030029
|
9-D1c-PhytoP
|
(S,E)-11-((1R,2S,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030008
|
9-D1t-PhytoP
|
11-((1R,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-9S-hydroxyundec-10E-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030045
|
9-E1c-PhytoP
|
(S,E)-11-((1R,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030043
|
9-E1t-PhytoP
|
(S,E)-11-((1S,2R,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030030
|
9-epi-9-D1c-PhytoP
|
(R,E)-11-((1R,2S,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030007
|
9-epi-9-D1t-PhytoP
|
11-((1R,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-9R-hydroxyundec-10E-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030046
|
9-epi-9-E1c-PhytoP
|
(R,E)-11-((1R,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030044
|
9-epi-9-E1t-PhytoP
|
(R,E)-11-((1S,2R,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030039
|
ent-16-D1c-PhytoP
|
8-((1S,2R,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030042
|
ent-16-D1t-PhytoP
|
8-((1R,2S,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030055
|
ent-16-E1c-PhytoP
|
8-((1S,2R,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030058
|
ent-16-E1t-PhytoP
|
8-((1R,2S,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030040
|
ent-16-epi-16-D1c-PhytoP
|
8-((1S,2R,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030041
|
ent-16-epi-16-D1t-PhytoP
|
8-((1R,2S,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030056
|
ent-16-epi-16-E1c-PhytoP
|
8-((1S,2R,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030057
|
ent-16-epi-16-E1t-PhytoP
|
8-((1R,2S,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)octanoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030033
|
ent-9-D1c-PhytoP
|
(R,E)-11-((1S,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030031
|
ent-9-D1t-PhytoP
|
(R,E)-11-((1R,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030049
|
ent-9-E1c-PhytoP
|
(R,E)-11-((1S,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030047
|
ent-9-E1t-PhytoP
|
(R,E)-11-((1R,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030034
|
ent-9-epi-9-D1c-PhytoP
|
(S,E)-11-((1S,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030032
|
ent-9-epi-9-D1t-PhytoP
|
(S,E)-11-((1R,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030050
|
ent-9-epi-9-E1c-PhytoP
|
(S,E)-11-((1S,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02030048
|
ent-9-epi-9-E1t-PhytoP
|
(S,E)-11-((1R,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
Octadecanoids [FA02]
|
Phytoprostanes [FA0203]
|
326.21
|
C18H30O5
|
|
LMFA02050001
|
(9Z,11E)-12-((3S,5R)-5-((R)-1-hydroxypropyl)-1,2-dioxolan-3-yl)dodeca-9,11-dienoic acid
|
(9Z,11E)-12-((3S,5R)-5-((R)-1-hydroxypropyl)-1,2-dioxolan-3-yl)dodeca-9,11-dienoic acid
|
Octadecanoids [FA02]
|
Octadeca-1,2-dioxolanes [FA0205]
|
326.21
|
C18H30O5
|
|
LMFA02050002
|
(9Z,11E)-12-((3S,5S)-5-((S)-1-hydroxypropyl)-1,2-dioxolan-3-yl)dodeca-9,11-dienoic acid
|
(9Z,11E)-12-((3S,5S)-5-((S)-1-hydroxypropyl)-1,2-dioxolan-3-yl)dodeca-9,11-dienoic acid
|
Octadecanoids [FA02]
|
Octadeca-1,2-dioxolanes [FA0205]
|
326.21
|
C18H30O5
|
|
LMFA03000025
|
|
12,17;13,17-Diepoxy-16-hydroxy-9Z-octadecenoic acid
|
Eicosanoids [FA03]
|
Other Eicosanoids [FA0300]
|
326.21
|
C18H30O5
|
|
LMFA03010011
|
2,3-dinor-11b-PGF2alpha
|
9S,11S,15S-trihydroxy-2,3-dinor-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
326.21
|
C18H30O5
|
|
LMFA03010169
|
2,3-dinor-PGE1
|
9-oxo-11R,15S-dihydroxy-2,3-dinor-13E-prostenoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
326.21
|
C18H30O5
|
|
LMFA03010212
|
Dinor-PGF2alpha
|
2,3-dinor-9S,11R,15S-trihydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
326.21
|
C18H30O5
|
|
LMFA03110010
|
2,3-Dinor-8-iso-PGF2alpha
|
9S,11R,15S-trihydroxy-2,3-dinor-5Z,13E-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
326.21
|
C18H30O5
|